Mr Shaker Hanna Haddad, MD | |
12813 W Warren Ave, Dearborn, MI 48126-1532 | |
(313) 581-8090 | |
Not Available |
Full Name | Mr Shaker Hanna Haddad |
---|---|
Gender | Male |
Speciality | Pediatrics |
Location | 12813 W Warren Ave, Dearborn, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093788069 | NPI | - | NPPES |
4301048228 | Other | MI | CONTROLLED SUBSTANCE LIC. |
1093788069 | Medicaid | MI | |
4301048228 | Other | MI | PHYSICIAN LICENSE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208000000X | Pediatrics | 4301048228 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Shaker Hanna Haddad, MD 12813 W Warren Ave, Dearborn, MI 48126-1532 Ph: (313) 581-8090 | Mr Shaker Hanna Haddad, MD 12813 W Warren Ave, Dearborn, MI 48126-1532 Ph: (313) 581-8090 |
News Archive
Ground-breaking research is harnessing the unique properties of diamonds to develop a new generation of lasers that could lead to many benefits, from better treatment of skin complaints and diabetes-related eye conditions to improved pollution monitoring and aeronautical engineering
The University of Florida's Institute on Aging has received close to $15 million from the National Institutes of Health to construct an almost 40,000-square-foot complex for clinical and translational research.
Yale researchers describe a breakthrough in safe and effective administration of potential antiviral drugs - small interfering RNA (siRNA) molecules that silence genes - the first step in development of a new kind of treatment for sexually transmitted diseases (STDs). The work is reported May 4 as an advance online publication of Nature Materials.
David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).
› Verified 9 days ago
Mrs. Kingkhan Boriboon, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 3850 Pelham St, Dearborn, MI 48124 Phone: 313-562-9500 Fax: 313-562-7567 | |
Rannan Kased, D.O Pediatrics Medicare: Medicare Enrolled Practice Location: 4700 Schaefer Rd Ste 245255, Dearborn, MI 48126 Phone: 313-561-5100 Fax: 313-565-0309 | |
Dr. Doss Nicolas Doss, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Henry Ford Health System, 5500 Auto Club Dr, Dearborn, MI 48126 Phone: 313-425-4700 | |
Saba Javaid, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 19401 Hubbard Dr, Dearborn, MI 48126 Phone: 313-982-4400 | |
Kathleen B. Blumer, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: Henry Ford Health System, 19401 Hubbard Drive, Dearborn, MI 48126 Phone: 313-982-8330 Fax: 313-982-8294 | |
Dr. Azmathullah Khan, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4700 Greenfield Rd, Dearborn, MI 48126 Phone: 313-945-6100 Fax: 313-945-5260 | |
Dr. Alex Elsabbagh, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1000 N Telegraph Rd, Dearborn, MI 48128 Phone: 313-274-6666 Fax: 313-274-4466 |